Comparing Bempedoic Acid vs Praluent
| Bempedoic acid | Praluent (alirocumab) |
|
|---|
| Bempedoic acid | Praluent (alirocumab) |
|
|---|---|---|
|
Prescription only
Bempedoic acid has been shown in studies to decrease LDL-C (“bad cholesterol”) levels and may be given in combination with other cholesterol-lowering treatments, or it can be used alone. It is also... View more |
Prescription only
Praluent is a PCSK9 inhibitor that may be used to reduce LDL-C levels in people with primary hyperlipidemia, genetically high cholesterol, or to reduce the risk of a heart attack, stroke, or... View more |
Related suggestions High Cholesterol
Cardiovascular Risk Reduction
High Cholesterol, Familial Heterozygous
|
| More about Bempedoic acid | More about Praluent (alirocumab) | |
| Ratings & Reviews | ||
|
Bempedoic acid has an average rating of 7.7 out of 10 from a total of 19 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 5% reported a negative effect. |
Praluent has an average rating of 6.3 out of 10 from a total of 306 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 31% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Bempedoic acid side effects |
View all Praluent side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
|
|
| Brand Names | ||
| Nexletol |
N/A |
|
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
21 hours |
480 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 55 drugs are known to interact with Bempedoic acid:
|
A total of 3 drugs are known to interact with Praluent:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | ||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||
| First Approval Date | ||
|
N/A |
July 24, 2015 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.